M A Vadas

6.5k total citations · 4 hit papers
48 papers, 5.5k citations indexed

About

M A Vadas is a scholar working on Immunology, Molecular Biology and Immunology and Allergy. According to data from OpenAlex, M A Vadas has authored 48 papers receiving a total of 5.5k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Immunology, 14 papers in Molecular Biology and 13 papers in Immunology and Allergy. Recurrent topics in M A Vadas's work include Immune Response and Inflammation (14 papers), Cell Adhesion Molecules Research (13 papers) and Neutrophil, Myeloperoxidase and Oxidative Mechanisms (9 papers). M A Vadas is often cited by papers focused on Immune Response and Inflammation (14 papers), Cell Adhesion Molecules Research (13 papers) and Neutrophil, Myeloperoxidase and Oxidative Mechanisms (9 papers). M A Vadas collaborates with scholars based in Australia, United States and United Kingdom. M A Vadas's co-authors include Jennifer R. Gamble, Angel F. López, John M. Harlan, S J Klebanoff, A M Waltersdorph, Colin J. Sanderson, IG Young, HD Campbell, Nicos A. Nicola and D Metcalf and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

M A Vadas

48 papers receiving 5.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Stimulation of the adherence of neutrophils to umbilical vein endothelium by human recombinant tumor necrosis factor.

1985 876 citations Jennifer R. Gamble, John M. Harlan et al. Proceedings of the National Academy of Sciences profile →
Recombinant human interleukin 5 is a selective activator of human eosinophil function.

1988 809 citations Angel F. López, Colin J. Sanderson et al. The Journal of Experimental Medicine profile →
Stimulation of neutrophils by tumor necrosis factor.

1986 733 citations S J Klebanoff, M A Vadas et al. The Journal of Immunology profile →
Recombinant human granulocyte-macrophage colony-stimulating factor stimulates in vitro mature human neutrophil and eosinophil function, surface receptor expression, and survival.

1986 623 citations Angel F. López, Dominic J. Williamson et al. Journal of Clinical Investigation profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M A Vadas Australia	30	2.9k	1.3k	1.2k	981	618	48	5.5k
Marika Sarfati Canada	51	4.9k 1.7×	1.5k 1.2×	1.5k 1.2×	1.1k 1.2×	289 0.5×	128	7.5k
Itsuo Iwamoto Japan	51	4.4k 1.5×	2.5k 2.0×	1.1k 0.9×	997 1.0×	824 1.3×	167	7.7k
Jérôme Pène France	34	3.1k 1.1×	1.5k 1.2×	747 0.6×	1.1k 1.1×	271 0.4×	76	5.4k
Clemens A. Dahinden Switzerland	46	4.3k 1.5×	2.6k 2.0×	1.1k 0.9×	2.1k 2.1×	486 0.8×	98	7.6k
Pierre Graber Switzerland	34	2.2k 0.7×	504 0.4×	1.5k 1.2×	579 0.6×	259 0.4×	87	4.7k
Yasusada Miura Japan	41	2.6k 0.9×	1.3k 1.0×	2.3k 1.9×	662 0.7×	574 0.9×	280	7.3k
Otto Götze Germany	46	4.2k 1.4×	699 0.5×	1.3k 1.0×	326 0.3×	368 0.6×	132	6.4k
José-Carlos Gutierrez-Ramos United States	41	5.1k 1.8×	1.8k 1.4×	1.5k 1.2×	1.2k 1.2×	578 0.9×	60	8.1k
Jean‐François Gauchat Canada	39	3.4k 1.2×	834 0.7×	1.1k 0.9×	706 0.7×	220 0.4×	95	5.4k
F Rousset France	38	5.6k 1.9×	1.0k 0.8×	1.1k 0.9×	1.2k 1.2×	198 0.3×	69	8.5k

Countries citing papers authored by M A Vadas

Since Specialization

Citations

This map shows the geographic impact of M A Vadas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M A Vadas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M A Vadas more than expected).

Fields of papers citing papers by M A Vadas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M A Vadas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M A Vadas. The network helps show where M A Vadas may publish in the future.

Co-authorship network of co-authors of M A Vadas

This figure shows the co-authorship network connecting the top 25 collaborators of M A Vadas. A scholar is included among the top collaborators of M A Vadas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M A Vadas. M A Vadas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Vestweber, Dietmar, Lena Claesson‐Welsh, Donald M. McDonald, et al.. (2023). Report from the 2023 workshop on endothelial permeability, edema and inflammation. Nature Cardiovascular Research. 2(12). 1120–1124. 1 indexed citations

Shannon, M, Leeanne S. Coles, M A Vadas, & Peter N. Cockerill. (1997). Signals for Activation of the GM-CSF Promoter and Enhancer in T Cells. Critical Reviews in Immunology. 17(3-4). 301–323. 67 indexed citations

Coles, Leeanne S., et al.. (1996). Cold Shock Domain Proteins Repress Transcription from the GM-CSF Promoter. Nucleic Acids Research. 24(12). 2311–2317. 50 indexed citations

Osborne, Cameron S., M A Vadas, & Peter N. Cockerill. (1995). Transcriptional regulation of mouse granulocyte-macrophage colony-stimulating factor/IL-3 locus. The Journal of Immunology. 155(1). 226–235. 31 indexed citations

Kazazi, F, Joon Chang, Angel F. López, M A Vadas, & Anthony L. Cunningham. (1994). Interleukin 4 and human immunodeficiency virus stimulate LFA-1-ICAM-1-mediated aggregation of monocytes and subsequent giant cell formation. Journal of General Virology. 75(10). 2795–2802. 27 indexed citations

Barbara, J. A. J., William Smith, Jennifer R. Gamble, et al.. (1994). Dissociation of TNF- cytotoxic and proinflammatory activities by p55 and p75 receptor-selective TNF- mutants. 13. 843–850. 3 indexed citations

Cockerill, Peter N., M Shannon, Andrew G. Bert, Gregory R. Ryan, & M A Vadas. (1993). The granulocyte-macrophage colony-stimulating factor/interleukin 3 locus is regulated by an inducible cyclosporin A-sensitive enhancer.. Proceedings of the National Academy of Sciences. 90(6). 2466–2470. 173 indexed citations

Kazazi, F, Paul Malafiej, Angel F. López, et al.. (1992). Recombinant interleukin 4 stimulates human immunodeficiency virus production by infected monocytes and macrophages. Journal of General Virology. 73(4). 941–949. 49 indexed citations

López, Angel F., et al.. (1992). Regulation of human eosinophil production and function by interleukin-5.. PubMed. 57. 549–71. 14 indexed citations

10.

López, Angel F., Joanna M. Woodcock, David Gillis, et al.. (1992). IL-5 and related eosinophilopoietic cytokines: their receptors and their role in eosinophil-mediated inflammatory reactions.. 205–227. 1 indexed citations

11.

Phillips, Julie A., et al.. (1989). Synthesis and expression of the gene encoding human interleukin-3. Gene. 84(2). 501–507. 6 indexed citations

12.

López, Angel F., Colin J. Sanderson, Jennifer R. Gamble, et al.. (1988). Recombinant human interleukin 5 is a selective activator of human eosinophil function.. The Journal of Experimental Medicine. 167(1). 219–224. 809 indexed citations breakdown →

13.

Marasco, Wayne A., et al.. (1988). Recombinant human tumor necrosis factor-alpha. Regulation of N-formylmethionylleucylphenylalanine receptor affinity and function on human neutrophils.. Journal of Clinical Investigation. 81(3). 759–765. 145 indexed citations

14.

Williamson, Dominic J., C. Glenn Begley, M A Vadas, & D Metcalf. (1988). The detection and initial characterization of colony-stimulating factors in synovial fluid.. PubMed. 72(1). 67–73. 64 indexed citations

15.

López, Angel F., C. Glenn Begley, Dominic J. Williamson, et al.. (1986). Murine eosinophil differentiation factor. An eosinophil-specific colony-stimulating factor with activity for human cells.. The Journal of Experimental Medicine. 163(5). 1085–1099. 134 indexed citations

16.

López, Angel F., Dominic J. Williamson, Jennifer R. Gamble, et al.. (1986). Recombinant human granulocyte-macrophage colony-stimulating factor stimulates in vitro mature human neutrophil and eosinophil function, surface receptor expression, and survival.. Journal of Clinical Investigation. 78(5). 1220–1228. 623 indexed citations breakdown →

17.

Vadas, M A, Angel F. López, & Dominic J. Williamson. (1985). Selective enhancement of the expression of granulocyte functional antigens 1 and 2 on human neutrophils.. Proceedings of the National Academy of Sciences. 82(8). 2503–2507. 12 indexed citations

18.

Sewell, William A., J J Munoz, Roland Scollay, & M A Vadas. (1984). Studies on the mechanism of the enhancement of delayed-type hypersensitivity by pertussigen.. The Journal of Immunology. 133(4). 1716–1722. 29 indexed citations

19.

Vadas, M A & Claude C.A. Bernard. (1981). Selective inhibition of the induction phase of delayed type hypersensitivity in mice by niridazole. Clinical Immunology and Immunopathology. 20(3). 313–320. 1 indexed citations

20.

Vadas, M A, A Butterworth, Barbara Sherry, et al.. (1980). Interactions between human eosinophils and schistosomula of Schistosoma mansoni. I. Stable and irreversible antibody-dependent adherence.. The Journal of Immunology. 124(3). 1441–1448. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact